Literature DB >> 2188920

Onchocerciasis.

H R Taylor1.   

Abstract

Onchocerciasis is a devastating blinding disease caused by the parasite Onchocerca volvulus that infects about 80 million people, causing blindness and visual impairment in 1-2 million people. In hyperendemic areas, more than half of the population will become blind from onchocerciasis before they die. Blindness is the most important effect of the disease and results, in part, from direct invasion of the eye by microfilariae. The recent development of ivermectin has revolutionized our ability to treat this disease. An annual oral dose of only 150 mg/kg completely suppresses the disease manifestations. Programs for the community-based mass distribution of ivermectin are now being conducted and promise to control this major blinding scourge.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2188920     DOI: 10.1007/bf00158317

Source DB:  PubMed          Journal:  Int Ophthalmol        ISSN: 0165-5701            Impact factor:   2.031


  23 in total

1.  Morphology of posterior segment lesions of the eye in patients with onchocerciasis.

Authors:  A C Bird; J Anderson; H Fuglsang
Journal:  Br J Ophthalmol       Date:  1976-01       Impact factor: 4.638

2.  Effect of single-dose ivermectin therapy on human Onchocerca volvulus infection with onchocercal ocular involvement.

Authors:  H S Newland; A T White; B M Greene; S A D'Anna; E Keyvan-Larijani; M A Aziz; P N Williams; H R Taylor
Journal:  Br J Ophthalmol       Date:  1988-08       Impact factor: 4.638

3.  The effects of ivermectin on transmission of Onchocerca volvulus.

Authors:  E W Cupp; M J Bernardo; A E Kiszewski; R C Collins; H R Taylor; M A Aziz; B M Greene
Journal:  Science       Date:  1986-02-14       Impact factor: 47.728

4.  Efficacy and tolerance of ivermectin in human onchocerciasis.

Authors:  M A Aziz; S Diallo; I M Diop; M Lariviere; M Porta
Journal:  Lancet       Date:  1982-07-24       Impact factor: 79.321

5.  Recent developments in the treatment of onchocerciasis.

Authors:  H R Taylor
Journal:  Bull World Health Organ       Date:  1984       Impact factor: 9.408

6.  [Ivermectin and human onchocerciasis. A study of 234 onchocerciasis patients in the Republic of Mali].

Authors:  P Vingtain; E Pichard; J Ginoux; S M Coulibaly; Y Bissan; P Ranque; B Thillaye
Journal:  Bull Soc Pathol Exot Filiales       Date:  1988

7.  Comparison of ivermectin and diethylcarbamazine in the treatment of onchocerciasis.

Authors:  B M Greene; H R Taylor; E W Cupp; R P Murphy; A T White; M A Aziz; H Schulz-Key; S A D'Anna; H S Newland; L P Goldschmidt
Journal:  N Engl J Med       Date:  1985-07-18       Impact factor: 91.245

8.  Double-blind study of ivermectin and diethylcarbamazine in African onchocerciasis patients with ocular involvement.

Authors:  M Lariviere; P Vingtain; M Aziz; B Beauvais; D Weimann; F Derouin; J Ginoux; H Schulz-Key; P Gaxotte; D Basset
Journal:  Lancet       Date:  1985-07-27       Impact factor: 79.321

9.  Ocular findings in a double-blind study of ivermectin versus diethylcarbamazine versus placebo in the treatment of onchocerciasis.

Authors:  K Y Dadzie; A C Bird; K Awadzi; H Schulz-Key; H M Gilles; M A Aziz
Journal:  Br J Ophthalmol       Date:  1987-02       Impact factor: 4.638

10.  Ivermectin treatment of patients with severe ocular onchocerciasis.

Authors:  H R Taylor; R D Semba; H S Newland; E Keyvan-Larijani; A White; Z Dukuly; B M Greene
Journal:  Am J Trop Med Hyg       Date:  1989-05       Impact factor: 2.345

View more
  4 in total

Review 1.  Treatment of onchocerciasis.

Authors:  Y Van Laethem; C Lopes
Journal:  Drugs       Date:  1996-12       Impact factor: 9.546

2.  Prevalence of blindness and low vision of people over 30 years in the Wenchi district, Ghana, in relation to eye care programmes.

Authors:  A C Moll; A J van der Linden; M Hogeweg; W E Schader; J Hermans; R J de Keizer
Journal:  Br J Ophthalmol       Date:  1994-04       Impact factor: 4.638

Review 3.  Points of action in the campaign against blindness in developing countries.

Authors:  J S Stilma; S Franken; M Hogeweg; P Hardus
Journal:  Doc Ophthalmol       Date:  1991       Impact factor: 2.379

4.  Automated retinal imaging and trend analysis - a tool for health monitoring.

Authors:  Karin Roesch; Tristan Swedish; Ramesh Raskar
Journal:  Clin Ophthalmol       Date:  2017-05-23
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.